These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 8988742)

  • 1. Dienogest, a novel synthetic steroid, overcomes hormone-dependent cancer in a different manner than progestins.
    Katsuki Y; Shibutani Y; Aoki D; Nozawa S
    Cancer; 1997 Jan; 79(1):169-76. PubMed ID: 8988742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
    Menendez JA; Oza BP; Colomer R; Lupu R
    Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Idoxifene antagonizes estradiol-dependent MCF-7 breast cancer xenograft growth through sustained induction of apoptosis.
    Johnston SR; Boeddinghaus IM; Riddler S; Haynes BP; Hardcastle IR; Rowlands M; Grimshaw R; Jarman M; Dowsett M
    Cancer Res; 1999 Aug; 59(15):3646-51. PubMed ID: 10446976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dienogest is a selective progesterone receptor agonist in transactivation analysis with potent oral endometrial activity due to its efficient pharmacokinetic profile.
    Sasagawa S; Shimizu Y; Kami H; Takeuchi T; Mita S; Imada K; Kato S; Mizuguchi K
    Steroids; 2008 Feb; 73(2):222-31. PubMed ID: 18061638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Animal studies on the endocrinological profile of dienogest, a novel synthetic steroid.
    Katsuki Y; Sasagawa S; Takano Y; Shibutani Y; Aoki D; Udagawa Y; Nozawa S
    Drugs Exp Clin Res; 1997; 23(2):45-62. PubMed ID: 9309380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progestin therapy for endometrial cancer: the potential of fourth-generation progestin (review).
    Banno K; Kisu I; Yanokura M; Tsuji K; Masuda K; Ueki A; Kobayashi Y; Yamagami W; Nomura H; Susumu N; Aoki D
    Int J Oncol; 2012 Jun; 40(6):1755-62. PubMed ID: 22366992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a mouse model for testing therapeutic agents: the anticancer effect of dienogest on endometrial neoplasms.
    Saito F; Tashiro H; Yamaguchi M; Honda R; Ohba T; Suzuki A; Katabuchi H
    Gynecol Endocrinol; 2016; 32(5):403-7. PubMed ID: 26680656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermal growth factor receptor signaling enhanced by long-term medroxyprogesterone acetate treatment in endometrial carcinoma.
    Zhao S; Chen X; Lu X; Yu Y; Feng Y
    Gynecol Oncol; 2007 Apr; 105(1):45-54. PubMed ID: 17240435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyproterone, norethindrone, medroxyprogesterone and levonorgestrel are less potent local human growth hormone and insulin-like growth factor I secretion stimulators than progesterone in human breast cancer explants expressing the estrogen receptor.
    Milewicz T; Kolodziejczyk J; Krzysiek J; Basta A; Sztefko K; Kurek S; Stachura J; Gregoraszczuk EL
    Gynecol Endocrinol; 2002 Aug; 16(4):319-29. PubMed ID: 12396561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Progestogen therapy in the treatment of endometrial cancer--clinical results and mechanism of steroid action].
    Okada H
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):924-8. PubMed ID: 2968780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Five novel hormone-responsive cell lines derived from murine mammary ductal carcinomas: in vivo and in vitro effects of estrogens and progestins.
    Lanari C; Lüthy I; Lamb CA; Fabris V; Pagano E; Helguero LA; Sanjuan N; Merani S; Molinolo AA
    Cancer Res; 2001 Jan; 61(1):293-302. PubMed ID: 11196177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphological and biochemical features of a medroxyprogesterone acetate (MPA)-resistant MCF-7 breast cancer cell line.
    Gibelli N; Zibera C; Sica G; Carbone M; Pedrazzoli P; Robustelli della Cuna G
    Anticancer Res; 1994; 14(1A):37-43. PubMed ID: 7909420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of estradiol with micronized progesterone or medroxyprogesterone acetate on risk markers for breast cancer in postmenopausal monkeys.
    Wood CE; Register TC; Lees CJ; Chen H; Kimrey S; Cline JM
    Breast Cancer Res Treat; 2007 Jan; 101(2):125-34. PubMed ID: 16841178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Membrane-receptor initiated proliferative effects of dienogest in human breast cancer cells.
    Schneck H; Ruan X; Seeger H; Cahill MA; Fehm T; Mueck AO; Neubauer H
    Gynecol Endocrinol; 2013 Feb; 29(2):160-3. PubMed ID: 23116217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of tumor-associated fatty acid synthase activity antagonizes estradiol- and tamoxifen-induced agonist transactivation of estrogen receptor (ER) in human endometrial adenocarcinoma cells.
    Menendez JA; Oza BP; Atlas E; Verma VA; Mehmi I; Lupu R
    Oncogene; 2004 Jun; 23(28):4945-58. PubMed ID: 15094777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53-dependent inhibition of progestin-induced VEGF expression in human breast cancer cells.
    Liang Y; Wu J; Stancel GM; Hyder SM
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):173-82. PubMed ID: 15860260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of medroxyprogesterone acetate on the anticellular activity of 5-fluorouracil against human breast and stomach cancer cells].
    Ishida H; Okabe M; Gomi K; Horiuchi R
    Gan To Kagaku Ryoho; 1993 Apr; 20(5):625-30. PubMed ID: 8470920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro evaluation of the growth inhibition and apoptosis effect of mifepristone (RU486) in human Ishikawa and HEC1A endometrial cancer cell lines.
    Navo MA; Smith JA; Gaikwad A; Burke T; Brown J; Ramondetta LM
    Cancer Chemother Pharmacol; 2008 Aug; 62(3):483-9. PubMed ID: 18004570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progestin regulation of vascular endothelial growth factor in human breast cancer cells.
    Hyder SM; Murthy L; Stancel GM
    Cancer Res; 1998 Feb; 58(3):392-5. PubMed ID: 9458078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medroxyprogesterone acetate inhibits human pancreatic carcinoma cell growth by inducing apoptosis in association with Bcl-2 phosphorylation.
    Abe M; Yamashita J; Ogawa M
    Cancer; 2000 May; 88(9):2000-9. PubMed ID: 10813710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.